Related Experiment Video

Updated: Jul 7, 2026

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure

Serge Masson1, Roberto Latini

  • 1Department of Cardiovascular Research, Laboratory of Cardiovascular Clinical Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

The American Journal of Cardiology
|February 22, 2008
PubMed

Insights

Measuring amino-terminal pro-B-type natriuretic peptide (NT-proBNP) effectively predicts risks in chronic heart failure (HF). Serial NT-proBNP measurements offer additional prognostic value for adverse outcomes in HF patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Research

Background:

  • Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) is a key biomarker in heart failure (HF).
  • Elevated NT-proBNP levels are strongly associated with increased mortality risk in chronic HF patients.
  • Current guidelines recommend NT-proBNP measurement for prognostication across HF severity spectrum.

Purpose of the Study:

  • To evaluate the prognostic utility of NT-proBNP levels in chronic heart failure (HF).
  • To determine the value of serial NT-proBNP measurements for predicting adverse outcomes in HF.
  • To assess the impact of confounding factors on NT-proBNP's prognostic value.

Main Methods:

  • Retrospective analysis of NT-proBNP levels in a cohort of chronic HF patients.
  • Correlation of NT-proBNP concentrations with adverse events like mortality and HF hospitalization.
  • Assessment of NT-proBNP changes over time in relation to clinical stability.

Main Results:

  • NT-proBNP levels are potent independent predictors of hazard in chronic HF.
  • Repeated NT-proBNP measurements provide additional prognostic information for adverse outcomes.
  • A significant increase in morbidity and mortality is observed with NT-proBNP >1,000 ng/L.
  • NT-proBNP retains prognostic value despite confounding factors like renal dysfunction and obesity.

Conclusions:

  • Serial assessment of NT-proBNP is valuable for prognostication in outpatients with chronic HF.
  • Regular NT-proBNP monitoring, alongside clinical assessment, is recommended for managing HF patients.
  • NT-proBNP serves as a reliable tool for risk stratification and guiding treatment decisions in chronic HF.

More Related Videos

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...